Gerren McHam, vice president of Government and External Affairs, API Innovation Center, breaks down how China's new export control regulations expose drugmakers to operational risks that have yet to draw significant industry attention.
Gerren McHam
Advertisement
Gerren McHam is vice president, government and external affairs, at the API Innovation Center.
Articles by Gerren McHam
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
3
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5